LIFEMD, INC. Accounts Receivable
LIFEMD, INC. (LFMD) had Accounts Receivable of $11.26 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2026-08-05
- 2026-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $11.26M.
- 2026-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $9.86M.
- 2025-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $9.31M.
- 2025-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $9.24M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current | Accounts Receivable, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2026-06-30 | $11.26M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $9.86M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $9.31M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $9.24M 10-Q · filed 2025-11-17 | |
| 2025-06-30 | $7.33M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $10.19M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $10.46M 10-K · filed 2026-03-10 | $8.22M 10-K · filed 2025-03-11 |
| 2024-09-30 | $6.05M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $5.67M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $5.34M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $6.27M 10-Q · filed 2025-11-17 | $5.28M 10-K · filed 2024-03-11 |
| 2023-09-30 | $4.42M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $3.67M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $2.94M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $2.83M 10-K · filed 2025-03-11 | |
| 2022-09-30 | $2.54M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $2.51M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.80M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $980.05K 10-K · filed 2023-03-22 | |
| 2021-09-30 | $1.50M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $1.61M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $1.35M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $997.76K 10-K · filed 2022-03-07 | $648.42K 10-K · filed 2021-03-30 |
| 2020-09-30 | $414.34K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $436.02K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $282.48K 10-Q · filed 2020-05-19 | |
| 2019-12-31 | $97.45K 10-K · filed 2021-03-30 | |
| 2019-09-30 | $65.25K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $103.27K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $433.20K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $99.05K 10-K · filed 2020-03-30 | |
| 2018-09-30 | $175.63K 10-Q/A · filed 2018-12-04 | |
| 2018-06-30 | $64.05K 10-Q · filed 2018-08-17 | |
| 2018-03-31 | $85.80K 10-Q · filed 2018-06-27 | |
| 2017-12-31 | $128.19K 10-K · filed 2019-04-01 | $398.77K 10-K · filed 2018-04-02 |
| 2017-09-30 | $276.99K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $519.62K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $555.71K 10-Q · filed 2017-07-07 | |
| 2016-12-31 | $444.74K 10-K · filed 2018-04-02 | |
| 2016-09-30 | $474.92K 10-Q/A · filed 2017-11-13 | |
| 2016-06-30 | $451.07K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $299.34K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $154.44K 10-Q/A · filed 2017-11-13 | |
| 2015-09-30 | $131.72K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $135.32K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $73.45K 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $14.97K 10-K · filed 2016-03-30 | |
| 2014-09-30 | $110.62K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $85.27K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $116.58K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $77.47K 10-K · filed 2015-03-30 | |
| 2013-09-30 | $11.31K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $157.51K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $113.84K 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $49.69K 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |